ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $19.52 million versus the consensus estimate of $20.3 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.